Flerie is an active long-term life science investor with a focus on biotechnology and pharmaceutical investments globally. The company is based in Stockholm and London and manages a portfolio of investments in Europe, Israel and the USA. The main focus is on providing organizations that primarily operate in drug development with services and resources. Flerie was founded in 2011 and has its headquarters in Stockholm.